Galderma Laboratories, L.P. Overview
Company Headquarters: Lausanne, Switzerland
Founded: 1981
Workforce: 5,700
Company Working: Galderma Laboratories, L.P. (Galderma) develops products in the field of aesthetics, prescription medicines, and consumer care. Galderma Laboratories, L.P. offers a wide portfolio of products used to treat different dermatological conditions. The company is present in more than 100 countries, with six manufacturing units across the world. In October 2019, the business changed its name from Nestlé Skin Health to become the biggest independent dermatology company in the world. A group of prominent institutional investors, including the EQT VIII fund, Luxinva (an entirely owned subsidiary of the Abu Dhabi Investment Authority), PSP Investments, and others, purchased it. The company works with medical professionals from all around the world to address the demands of people's skin health throughout their lifetimes. The company has a strong presence in North America, Latin America, Asia-Pacific, Europe, the Middle East, and Africa.
Strategy
Galderma Laboratories, L.P. focuses on forming alliances with various healthcare professionals around the globe to address peoples' requirements for skin health. To enhance its product portfolio, the company also conducts research and development on medically supported and scientifically defined skin care products. Moreover, the company is focused on developing the broadest range of dermatology-related flagship brands and services, as well as on producing consumer and customer data insights. Additionally, it also focused on providing commercial excellence through its multichannel go-to-market methodology.
